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Mechanical thrombectomy with stent retrievers has proven to be safe and effective in 
endovascular treatment of acute ischemic stroke. Direct aspiration has shown 
revascularization rates comparable to stent retrievers in the recent ASTER and COMPASS 
trials, however the efficacy in routine clinical practice has not been shown so far. The aim of 
our study was to show that aspiration has equal clinical and technical outcomes compared to 
stent retriever thrombectomy in daily clinical practice. 
 
Methods 
We analysed data of patients with a LVO of the anterior circulation registered in the Dutch 
MR CLEAN Registry between March 2014 and June 2016. Primary outcome was functional 
outcome measured with the modified Rankin Scale (mRS) score. Secondary outcomes were 
reperfusion grade, periprocedural complication rate and procedure duration. Association of 
treatment technique with functional outcome was estimated with univariable and 
multivariable ordinal logistic regression analysis and expressed as cOR for a shift towards 
better outcome on the mRS. 
 
Results 
As first-line treatment modality, 207 of 1175 patients (17.6%) were treated with direct 
aspiration, and 968 (82.4%) by stent retriever. We observed no differences in functional 
outcome (adjusted cOR 1.020 (95% CI 0.68-1.52)) and periprocedural complications. 
Successful reperfusion (eTICI >2B) was similar. Duration of the procedure was shorter with 




Direct aspiration shows equal clinical outcomes as stent retriever thrombectomy in our large 
multicenter real-life cohort. We found no difference in complication rates and shorter 






Various recent randomized clinical trials have demonstrated that endovascular treatment 
(EVT) is safe and effective for patients with acute ischemic stroke with large vessel occlusion 
(LVO) of the anterior circulation.[1–8] In the vast majority of patients in the intervention 
arms of these trials, thrombectomy was performed with latest generation thrombectomy 
devices, so-called stent retrievers. 
The alternative technique of contact aspiration thrombectomy as first line treatment has long 
been debated. Early generation aspiration devices suffered several difficulties, many of which 
have been overcome by newer generations of large bore flexible catheters.[9–11]  
Proposed advantages of aspiration include usability, less injury to vessel wall, shorter 
procedure times and lower cost.[11–14] 
Case series and retrospective single centre data have shown acceptable results.[15] The 
recently published results of the ASTER trial showed similar revascularization rates for both 
techniques. ASTER was designed to show superiority of aspiration over stent retriever, but 
failed to do so. Clinical outcome, assessed as a secondary endpoint, was similar for both 
techniques.[16] The recently announced but yet to be published results of the COMPASS trial 
report comparable clinical outcome for both techniques.  
The purpose of our study was to compare first line strategy of direct aspiration to stent 
retriever thrombectomy regarding functional outcome, reperfusion grade, complication rate, 
and duration of interventional procedure in patients with a proximal arterial occlusion in the 







We analysed differences between groups of patients who were included in the MR CLEAN 
Registry.[17] The MR CLEAN Registry is a prospective, observational study in all centres 
that perform EVT in the Netherlands. In this registry, that started following the conclusion of 
the MR Clean trial on March 16 2014, all patients undergoing EVT (defined as entry into the 
angiography suite and arterial puncture) are registered. Data about patient characteristics, 
intervention procedure, complications, reperfusion grade, and clinical outcome are recorded. 
Data of patients included up to June 15, 2016 are processed and used in this analysis. Sixteen 
centres participated in the MR CLEAN trial and are considered MR CLEAN centres. Two 
other centres started performing EVT later on, and their patients were not included in the 
present study. The MR CLEAN Registry was approved by the medical ethics committee.  
 
Patients 
We included patients who underwent first-line treatment with direct aspiration or stent 
retriever. Patients treated with intra-arterial thrombolysis only, or with a MERCI device or 
other modality were excluded. Inclusion criteria for this study are age 18 years and older, 
intracranial proximal arterial occlusion in the anterior circulation (intracranial carotid artery 
(ICA, ICA-T) or middle (M1/M2) or anterior (A1/A2) cerebral artery) demonstrated by CT 
angiography (CTA) and arterial puncture within 6.5 hours of symptom onset.[17]  
 
Outcome measures 
Primary outcome measure was functional outcome on the modified Rankin Scale (mRS) score 
at 90 days, ranging from 0 (no symptoms) to 6 (dead). Secondary outcomes were reperfusion 
grade as according to the extended Thrombolysis in Cerebral Infarction (eTICI) scale score at 
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end of the intervention procedure, complication rate, and time to reperfusion. We also used 
the eTICI score as a measure of distal embolization. The eTICI score ranges from 0 (no 
antegrade reperfusion of the occluded vascular territory) to 3 (complete antegrade 
reperfusion). The eTICI score includes grade 2C (slow flow in a few distal cortical vessels or 
presence of small distal cortical emboli, corresponding to 90-99% reperfusion). To reach an 
eTICI score of 2B or higher, complete DSA runs including anteroposterior and lateral views 
after EVT were mandatory. If a lateral view was missing, 2A was the highest possible score. 
Successful reperfusion was defined as eTICI 2B-3.  
Relevant imaging datasets (baseline non-contrast CT (NCCT), baseline CT Angiography 
(CTA), interventional Digital Subtraction Angiography (DSA), and follow up imaging, if 
applicable) were collected, anonymized, stored in an imaging database (XNAT; NRG, St. 
Louis, Missouri, USA), and subsequently analysed by an imaging core lab. Observers were 
blinded to all clinical findings, with exception of clinical assessment of lesion location in the 
case of baseline NCCT. In separate sessions, the core lab evaluated ASPECT score on 
baseline CT, eTICI on DSA, and presence of intracranial haemorrhage on follow up CT.  
Complications that occurred during intervention, hospital admittance, or in the 3-month 
follow up period were registered and evaluated by the serious adverse event (SAE) 
committee. Medical records were searched for complications to prevent underreporting. These 
included intracranial haemorrhage, progression of ischemic stroke (resulting in a decline of at 
least 4 points on the NIHSS), new ischemic stroke, extracranial haemorrhage, and death.  
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Intracranial haemorrhage on follow up imaging was classified according to the Heidelberg 
criteria[18] and was considered symptomatic if the patient had died or had deteriorated 
neurologically (a decline of at least 4 points on the NIHSS), and the haemorrhage was related 
to the clinical deterioration (according to Heidelberg criteria). Symptomatic intracranial 
haemorrhage (sICH) was assessed by the SAE committee after evaluation of medical reports 
and imaging assessment. 
 
Treatment  
Patients were treated according to national guidelines for treatment of acute ischemic stroke, 
including intravenous thrombolysis if indicated.[17] Choice of clot retriever method was left 
to the attending physician’s preference. Direct aspiration was defined as aspiration with a 
syringe or mechanical pump on a large bore catheter near the occluding clot.  
Anaesthetic management varied depending on local protocols. In most centres patients were 
treated primarily with local anaesthetics only. In two hospitals, general anaesthesia was 
applied in almost all patients. In two centres general anaesthesia and local anaesthesia were 
used equally.   
 
Statistical analyses 
Baseline characteristics are presented in a descriptive way as mean and standard deviation 
(SD), median and interquartile range (IQR), or frequency (%), and compared between patients 
who underwent first treatment with aspiration versus stent retriever thrombectomy. 
Differences between the groups were tested with Pearsons chi-square test in case of 
ordinal/nominal variables. All data sets with continuous variables were checked for normality 
of distribution using a normal probability plot and the Kolmogorov-Smirnov test. For 
comparison of continuous variables we used the unpaired T-test combined with Levene’s test 
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to check for homogeneity. If the distribution was not normal, we used the Mann-Whitney-U 
test. The level of significance was set at 0.05. 
 
Multivariable ordinal regression analyses were performed to identify factors predictive for 
clinical outcome (mRS) at 3 months. Potential factors that were included in this analysis were 
determined based on (i) any (clinical) significant group difference in the comparison of 
baseline characteristics and (ii) factors known to influence outcome such as baseline NIHSS 
score and pre-stroke mRS score. Relations were expressed as odds ratios with corresponding 
95% confidence intervals. We conducted a correlation analysis, calculating the Spearman rho 
on the independent variables before performing the ordinal regression analyses to prevent a 
misinterpretation of the results caused by multicollinearity. 
 
Missing values 
Missing NIHSS scores were retrospectively scored with a standardized score chart based on 
information from the reported neurological examination. If successful reperfusion was not 
achieved during EVT, the time of last contrast bolus injection was used as a proxy for time of 
duration of the procedure. Any mRS score of 0 to 5 assessed within 30 days was considered 
not valid and treated as missing. These values were therefore replaced by mRS scores derived 
from multiple imputation.[19] All descriptive analyses include all patients without imputation 
of the data. In order to make unbiased estimates of associations between intervention and 
outcome, multiple imputation was performed with the following variables: age, sex, baseline 
NIHSS score, diabetes mellitus, previous myocardial infarction, previous stroke, pre-stroke 
mRS score, atrial fibrillation, intravenous thrombolysis prior to EVT, systolic blood pressure, 
baseline ASPECTS, occlusion segment, CTA collateral status, time from symptom onset to 
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start of EVT, time from symptom onset to successful reperfusion, eTICI score at the end of 
the intervention, and NIHSS score after 24-48 hours. 
All analyses were performed with SPSS 24 for Macintosh.  
Results 
In the MR CLEAN registry, 1628 patients have been registered between March 16, 2014 and 
June 15, 2016. For this analysis, 453 patients were excluded. Most of these (201) underwent 
catheterization only and no thrombectomy was performed, either because the target occlusion 
resolved, or due to distal migration of the clot. Another 45 underwent primary treatment other 
than by aspiration or stent retriever and were also excluded; in 67 patients, it was unclear 
which treatment method was used. The remaining 1175 patients were included, of whom 968 
were initially treated with stent retriever and 207 with aspiration (Figure 1).  
One of the sixteen intervention centres used aspiration as first-line strategy in most of the 
cases. In twelve centres stent retriever was the main first-line treatment modality. Three 
centres used both methods as initial approach equally.  
 
Baseline characteristics  
Pre-stroke mRS was higher in the aspiration group, and patients in the aspiration group more 
often underwent general anaesthesia (54% vs 24%, p<0.05). Level of occlusion differed 
significantly; patients in the aspiration group had a more distal occlusion site. Balloon guiding 
was used less in the aspiration group. The distribution of other baseline characteristics was 




Table 1. Baseline characteristics of patients treated with aspiration or stent retriever. 
 Aspiration 
       N= 207 
Stent retriever 
      N= 968 
 P value  
Demographics    
     Age, median (IQR)  68.50 (54-77) 69 (57-78) 0.50 
     Male, n (%) 112 (54) 516 (53) 0.89 
     NIHSS baseline, median (IQR) 16 (12-21) 16 (12-19) 0.59 
     Pre-stroke mRS, n (%) 
  
    0.02 
            0 119 (59) 663 (70)  
            1 29 (14) 116 (12)  
            2 24 (12) 64 (7)  
           >2 29 (14) 110 (12)  
Medical history, n (%)      
            Previous stroke 31 (15) 162 (17) 0.62 
            Myocardial infarction 37 (19) 151 (16) 0.39 
            Peripheral arterial disease 17 (9) 85 (9) 0.99 
           Atrial fibrillation 38 (19) 224 (23) 0.21 
Cardiovascular risk factors, n (%)      
     Hypertension 99 (48) 495 (52) 0.33 
     Hypercholesterolemia 67 (34) 279 (30) 0.32 
     Diabetes mellitus 27 (13) 168 (18) 0.15 
     Smoking  47 (23) 226 (24) 0.97 
Medication, n (%)      
    Antiplatelet use 77 (38) 313 (33) 0.19 
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    Coumadin 20 (10) 137 (14) 0.10 
    Statin 68 (34) 346 (37) 0.46 
Stroke characteristics, n (%)      
            IVT 156 (75) 741 (77) 0.73 
            Level of occlusion     0.02 
                    ICA intracranial 51 (25) 272 (28)  
                    M1proximal 51 (25) 246 (26)  
                    M1distal 56 (29) 309 (33)  
                    M2 29 (15) 96 (10)  
                    M3 3 (2) 6 (1)  
                    A1 0 (0) 2 (0.2)  
                    A2 1 (0.5) 1 (0.1)  
            ASPECTS subgroups,      0.91 
                     0-4 12 (6) 64 (7)  
                     5-7 50 (25) 235 (25)  
                     8-10 137 (69) 633 (68)  
           Collaterals      0.83 
          Absent collaterals  11 (6) 66 (7)  
          Filling <50% of occluded area  62 (33) 294 (32)  
          >50% but less than 100% 83 (44) 360 (40)  
Filling 100% of the 
occluded area  
32 (17) 188 (21)  
Workflow      
Transfer from primary stroke centre, 
n (%) 
120 (58) 527 (54) 0.40 
Onset to IVT, median (IQR) 25,5 (17-32) 24 (19-34) 0.92 
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195 (155-245) 0.57 
Balloon guiding yes, n (%) 30 (25) 591 (72) <0.0001 
Local anaesthesia only, n (%) 74 (31) 621 (61) <0.0001 
Conscious sedation, n (%) 23 (15) 128 (15) 0.99 
General anaesthesia, n (%)  110 (54) 219 (24) <0.0001 
Continuous data are presented as mean (SD) for normal distributed data or as median (IQR) 
for skewed data. P values indicate differences between patients treated with stent retriever and 
direct aspiration.  
Missing values: NIHSS baseline: 26 (2%), pre-stroke mRS: 21 (2%), Previous stroke: 7 
(0.6%), history MI; 20 (2%), history PAD; 25 (2%), history DM; 8 (0.7%), hypertension; 13 
(1%), AF; 16 (1%), hypercholesterolemia: 39 (3%), smoking: 276 (24%), antiplatelet therapy: 
14 (1%), Coumadin use: 8 (0.7%), statin: 25 (2%), IVT: 3 (0.3 %),  level of occlusion: 52 
(4%), ASPECTS: 44 (4%), collateral score: 79 (7%), conscious sedation: 175 (15%), general 
anaesthesia; 54 (3.5%), balloon guiding: >100. 
Time onset to IVT: 524 (45%), duration ER intervention hospital to groin: 366 (31%). 
Abbreviations: IQR, interquartile range; NIHSS, National Institute of Health Stroke Scale; 
mRS, modified Rankin Scale; IVT, intravenous thrombolysis; ICA, internal carotid artery; 
M(segment), middle cerebral artery; A(segment), middle cerebral artery; ASPECTS, Alberta 
Stroke Program Early CT Score; ER, emergency room; EVT, endovascular treatment.  
 
Functional outcome 
There was no significant difference in the distribution of the mRS between the treatment 
groups, with a common odds ratio (cOR) for a shift of at least 1-point improvement on the 
mRS after treatment with aspiration first of 0.962 (95% CI 0.73 -1.28). Adjustment for age, 
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intervention centre, collateral status, time from onset to groin, general anaesthesia, pre-stroke 
mRS and baseline NIHSS score did not change this significantly (acOR 1.020 (95% CI 0.68-
1.52)), (Figure 2).  
 
Technical outcome  
Successful reperfusion (eTICI >2B) was achieved slightly more often, although not 
significantly, in the aspiration group than in the stent retriever group (63% vs 56%; p=0.06). 
Duration of the endovascular procedure was shorter in the aspiration group: median 57 
minutes (IQR 35-73) vs. median 70 minutes (IQR 47-95, p= <0.0001, Table 2).  
 





P value  
Duration of procedure in 
minutes, median (IQR) 
56,5 (35-73) 70 (47-95) <0.0001 
ER first hospital to 
reperfusion in minutes/last 
contrast bolus, median (IQR) 
164 (137-
232) 
196 (151-245) <0.0001 
SAE any, n (%) 85 (41) 414 (43) 0.71 
   Intracranial haemorrhage 
total, n (%)  
18 (9) 55 (6) 0.14 
         sICH periprocedural  5 (28) 16 (30)  
         sICH after 24h 9 (50) 30 (56)  
         sICH after 48h 3 (17) 2 (4)  
         sICH at discharge  1 (6) 4 (7)  
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         sICH at follow-up 0 (0) 2 (4)  
Post EVT eTICI, n (%)     0.03 
             0 28 (14) 128 (13)  
             1 1 (1) 44 (5)  
             2A 46 (22) 250 (26)  
             2B 33 (16) 174 (18)  
             2C 24 (12) 85 (9)  
             3 70 (35) 271 (29)  
Successful reperfusion 
(eTICI 2B-3), n (%) 
127 (63) 530 (56) 0.06 
 NIHSS 12-48 hour, median 
(IQR) 
12 (4-18) 11 (4-17) 0.60 
 mRS 3 months follow-up, n 
(%) 
    0.72 
             0 9 (5) 47 (5)  
             1 19 (11) 113 (13)  
             2 41 (23) 175 (20)  
             >2 111 (62) 560 (63)  
Stroke progression resulting 
in neurodetoriation/death, n 
(%) 
17 (8) 101 (10) 0.40 
New ischemic stroke 
resulting in 
neurodetoriation/death, n (%) 
5 (2) 16 (2) 0.64 
Mortality, n (%) 56 (27) 256 (26) 0.93 
       Mortality within 7 days 27 (13) 137 (14) 0.76 
       Mortality within 1 month  45 (22) 213 (22) 1.00 
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Missing values: Time onset- reperfusion: 35 (0.3%), Time duration of procedure: 80 (7%), 
Moment of sICH: 1, Post EVT eTICI: 21 (2%), NIHSS 12-48 hours: 119 (10%), mRS 3 
months follow-up: 100 (9%). 
Abbreviations:  IQR, interquartile range; ER, emergency room; SAE, serious adverse events; 
eTICI, extended Thrombolysis in Cerebral Infarction; sICH, symptomatic intracranial 




sICH was seen in 18 patients (9%) in the aspiration group, vs. 55 (6%) in the stent retriever 
group (p = 0.14). Mortality did not differ significantly between both groups (27 % in the 
aspiration group vs. 26 % in the stent retriever group (p = 0.93), Table 2)  
Clinically significant new infarction occurred in 5 patients (2%) in the aspiration group vs. 16 
(2%) in the stent retriever group (p = 0.64). Distal embolization rates seemed the same in both 
groups, as reperfusion rates (especially eTICI 2B and 2C scores) were the same.  
 
First line strategy only  
Single pass successful reperfusion was achieved in 108 patients (52%) with aspiration and in 
458 (47%) with stent retriever thrombectomy (p = 0.53). If successful reperfusion was 
achieved after a single pass, median time of EVT was 40 (IQR 30-60) minutes with aspiration 
vs. 52 (IQR 35-75) minutes with stent retriever (p < 0.001). 
Single pass successful reperfusion rate was highest in case of a proximal M1 occlusion (70% 
with aspiration vs. 59% with stent retriever, p = 0.13) and lowest in case of an intracranial 
ICA occlusion (31% with aspiration vs. 30% with stent retriever p = 0.18).  
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Fifteen patients (3%) had a periprocedural sICH after single pass with stent retriever vs. 1 
(0.9%) with aspiration (p= 0.15).  
 
Additional treatment 
An additional attempt after first line strategy was performed in 45 patients (22%) in the 
aspiration group, and 248 (26%) in the stent retriever group (Figure 1). In the stent retriever 
group, 107 patients (11%) were converted to aspiration, of whom 52% achieved successful 
reperfusion. In the aspiration group 35 patients (17%) were converted to stent retriever 
treatment, in which 15 patients (43%) achieved successful reperfusion. For the second, third 
and fourth attempts, either aspiration or stent retriever were used, without differences between 
the groups. After these additional attempts, 26 (58%) patients achieved successful reperfusion 
in the aspiration group and 114 (46%) in the stent retriever group (p= 0.15).  
 
Discussion  
This study shows that in routine clinical practice similar technical and clinical results are 
achieved when EVT is performed by direct aspiration or stent retriever as first approach in 
patients with acute ischemic stroke due to large vessel occlusive stroke of the anterior 
circulation. The results of this large patient cohort are in line with those of earlier studies 
comparing the technical outcomes of these thrombectomy techniques and adds important 
results on clinical outcome.[11,12,14,16,20] Compared to RCTs our results more closely 
reflect the use of both techniques in daily clinical practice with patient selection according to 
current clinical guidelines. Both techniques were performed by experienced interventionalists, 
minimalizing learning curve effect. 
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Results of our study show equal reperfusion rates with a single pass of aspiration compared to 
stent retriever. However, aspiration showed shorter procedure times than thrombectomy by 
stent retriever. Consequently, the time from onset of symptoms to reperfusion was shorter in 
patients treated with aspiration. This finding is in line with the ASTER trial and reported but 
as of yet unpublished results of the COMPASS trial.   
Although favourable clinical outcome is strongly associated with time to reperfusion[21], we 
did not observe a significant difference in functional outcome between patients treated with 
aspiration or stent retriever. The latter may be related to several factors: First, general 
anaesthesia was more often applied in the aspiration than in the stent retriever group 
(aspiration 54% vs stent retriever 24%) whereas local anaesthesia was the most commonly 
used method in the stent retriever group (aspiration 31% vs stent retriever 61%). The role of 
type of anaesthesia on outcome remains unclear at this point. Although studies comparing 
general anaesthesia and conscious sedation in EVT showed equivalence, data comparing these 
two methods with local anaesthesia only are lacking.[22–25] Differences in general 
anaesthesia use are probably related to centre specific preferences.  
Second, pre-stroke mRS was higher in the aspiration group. However, for both of the above-
mentioned factors adjustment was applied in our analysis.  More likely, the time difference 
between the two procedures may be too short and the groups too small to provide significant 
differences in functional recovery. In the stent retriever group, 107 patients (11%) were 
converted to aspiration, of whom 52% achieved successful reperfusion. In the aspiration 
group 35 patients (17%) were converted to stent retriever treatment, 15 patients (43%) 
achieved successful reperfusion. This indicates that conversion to the aspiration strategy may 
be advantageous, if first attempts with stent retriever are failing and vice versa. 
The number of second passes for both techniques are in line with other studies.[16][20]  
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Safety   
Intracranial haemorrhage may be caused by reperfusion injury or by device induced vessel 
damage. The latter may be caused by manipulation of the intracranial vasculature with any 
thrombectomy device.[13] We found no difference in the occurrence of intracranial bleeding 
between both groups.  
A matter of concern in mechanical thrombectomy is the per procedural thrombus 
fragmentation leading to the spread of emboli in a previously uninvolved arterial territory.[26] 
We observed no differences with regard to clinically relevant infarction in another territory 
between the treatment groups. In addition, reperfusion rates were similar, especially eTICI 2B 
and 2C scores, indicating that both techniques probably induced same rates of thrombus 
fragmentation. This is in accordance with other studies.[16,27]  
Limitations  
This study is not a randomized clinical trial, however both groups had largely similar baseline 
characteristics and with this study design the results represent daily clinical practice in a large 
real life cohort. In this multicentre observational study not every centre used the same 
treatment protocols: for example anaesthetic management and choice of treatment modality 
varied. Significant differences in baseline characteristics (pre-stroke mRS, use of general 
anaesthesia, balloon guiding use, site of occlusion) seem to be less favourable for aspiration 
than stent retriever in our cohort, based on the current state of knowledge.  
Giving procedures in which final lateral DSA is missing a maximum eTICI score of 2A 
potentially leads to underreporting of successful reperfusion, we assume this occurred at a 
similar frequency in both groups and this would not influence our results. 
The combined treatment of stent retriever and aspiration could not be analysed separately; in 




The results of this large multicenter real life cohort study showed no difference in safety and 
outcome between direct aspiration and stent retriever thrombectomy as first line treatment 
strategy in acute stroke patients with a large vessel occlusion. Both approaches are equally 
effective in endovascular treatment of acute ischemic stroke. This study confirms in a real-life 
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Figure 1  
Title: Flow of patients through this study.  
Abbreviations: EVT, endovascular treatment; MR CLEAN, Multicentre Randomized Clinical 
Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands; DSA, Digital 
Subtraction Angiography.  
 
Figure 2  
Title: Distribution of scores on the modified Rankin Scale for the aspiration and stent retriever 
groups. 
Caption: There is no statistically significant difference between the groups in the overall 
distribution of scores in an analysis with univariable ordinal regression. There was no 
significant shift in the mRS distribution in favour of the aspiration strategy, with a cOR for a 
1-point improvement of score on the mRS of 0.962 (95% CI 0.725 -1.276). Results after 
adjustment for age, intervention centre, collaterals, time to groin, National Institutes of Health 
Stroke Scale score at baseline, general anaesthesia and pre-stroke mRS in an analysis with 
multivariable regression are essentially the same (acOR 1.020 (95% CI 0.68-1.52)). 
Abbreviations: mRS, modified Rankin Scale  
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